Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: The pattern of in vitro reactivity predicts the in vivo effect on different tumours

A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes

1986 • 1,787 citations

Lymphokine-activated killer cells: A new approach to immunotherapy of cancer

1985 • 314 citations

In Vivo Antitumor Activity of Tumor-Infiltrating Lymphocytes Expanded in Recombinant Interleukin-2

1987 • 250 citations

The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.

1989 • 215 citations

Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity.

1988 • 99 citations

Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.

1989 • 89 citations

Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity.

1986 • 77 citations

Unique and common tumor‐specific transplantation antigens of chemically induced mouse sarcomas

1978 • 57 citations

Murine melanoma-specific tumor rejection activity elicited by a purified, melanoma-associated antigen.

1986 • 42 citations

Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.

1977 • 41 citations

Therapy of Disseminated Tumors by Adoptive Transfer of Specifically Immune T Cells1

2015 • 39 citations

Immunogenicity of chemically induced murine colon cancers.

1979 • 29 citations

Stimulation of PIP2 hydrolysis by aluminum fluoride in resting T cell subsets of normal and autoimmune-prone lpr mice.

1989 • 19 citations

Generation of crossreacting tumor antigens in ascitic derivatives from murine methylcholanthrene‐induced sarcomas

1984 • 15 citations

Adoptive immunotherapy of a mouse colon carcinoma with recombinant interleukin-2 alone or combined with lymphokine-activated killer cells or tumor-immune lymphocytes

1990 • 15 citations

Effector phenotype and immunologic specificity of T cell-mediated adoptive therapy for a murine tumor that lacks intrinsic immunogenicity

1990 • 15 citations

Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens.

1986 • 12 citations

Partial Characterization of <italic>n</italic>-Butanol-Solubilized Rejection-Type Antigens of Syngeneic Murine Colon Tumors

1985 • 11 citations

Influence of the donors' clinical status on in vitro and in vivo tumor-cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organs

1989 • 11 citations

Adoptive immunotherapy of cancer with immune and activated lymphocytes: Experimental and clinical studies

1986 • 8 citations

Growth Inhibition of Murine Colonic Adenocarcinoma by Tumor Immune but not by IL-2-Activated or Alloactivated Lymphocytes

1987 • 5 citations

Treatment of a low immunogenic experimental tumour with alloactivated or tumour-immune lymphocytes

1987 • 3 citations

Adjuvant adoptive immunotherapy with IL2 and lymphocytes from tumor-bearing mice: in vitro tumor-stimulated lymphocytes are more effective than LAK cells.

1991 • 2 citations

Cell surface antigens of chemically induced fibrosarcomas: detection by a monoclonal antibody of a tumor-restricted Mr 12,000 protein gag antigen encoded by a dual-tropic murine leukemia virus.

1985 • 2 citations